Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 75Years
All Genders
NCT06365424

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Led by Xijing Hospital of Digestive Diseases · Updated on 2025-07-02

117

Participants Needed

1

Research Sites

520 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)

CONDITIONS

Official Title

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must have given written informed consent (signed and dated)
  • Participated in the PBC study with fenofibrate (NCT02823353)
  • Females of reproductive potential must use at least one barrier contraceptive and a second effective birth control method during the study and for at least 90 days after the last dose
  • Male subjects who are sexually active with female partners of reproductive potential must use barrier contraception and their female partners must use a second effective birth control method during the study and for at least 90 days after the last dose
Not Eligible

You will not qualify if you...

  • Treatment-related adverse event (AE) leading to fenofibrate discontinuation
  • A medical condition, other than PBC, that in the investigator's opinion would preclude full participation in the study or confound its results (e.g., cancer)
  • Known history of other liver diseases
  • For females, pregnancy or breast-feeding
  • Long-term use of immunosuppressive agents
  • Any other condition(s) that would compromise the safety of the subject or compromise the quality of the clinical study, as judged by the Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xijing Hospital

Xi'an, Shaanxi, China

Actively Recruiting

Loading map...

Research Team

Y

Yansheng Liu, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) | DecenTrialz